Read the most important and the latest news about CERVANTES trial here

I. CERVANTES study (protocol version v2.0) was authorised through Clinical Trial Information System (CTIS) in Austria, Belgium, Italy, Poland and Spain.

• Austria - 5 sites

• Belgium - 5 sites

• Italy - 1 site

• Poland - 5 sites

• Spain - 6 sites

II. CERVANTES Portuguese translation under preparation for Brazilian International Review Board (IRB) - registration of 3 sites

III. We got together; ESGO 2026 Copenhagen CERVANTES investigator meeting.

• Friday 27.2.2026 18:00-18:30 ESGO meeting room 1